ly-294002 Hydrochloride|CAS 934389-88-5|DC Chemicals

Cas No.:	934389-88-5
Chemical Name:	LY 294002 Hydrochloride
Synonyms:	4H-1-Benzopyran-4-one,2-(4-morpholinyl)-8-phenyl-, hydrochloride (1:1);2-morpholin-4-yl-8-phenylchromen-4-one,hydrochloride;LY 294002 hydrochloride;LY 294002, HYDROCHLORIDE SALT;LY 294002, HYDROCHLORIDE SALT, >99;2-(4-Morpholinyl)-8-phenyl-1(4H)-benzopyran-4-one hydrochloride;LY294002 hydrochloride;2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one hydrochloride;2-(Morpholin-4-yl)-8-phenyl-4H-chromen-4-one hydrochloride;EX-A1710;HY-10108A;934389-88-5;LY-294002 hydrochloride;2-?(4-?Morpholinyl)?-?8-?phenyl-4H-?1-?benzopyran-?4-?one Hydrochloride;;SR-01000076245;CCG-222014;DS-016248;NCGC00261395-01;C19H17NO3.HCl;2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one hydrochloride;NSC 697286; SF 1101;LY-294,002 hydrochloride;SR-01000076245-3;SR-01000076245-1;Tox21_500710;SCHEMBL5078472;AC-32574;CHEMBL1398499;EN300-657176;LP00710;L 9908;DTXSID50474691;CS-0021282;HB2266;CU-00000000012-1;OQZQSRICUOWBLW-UHFFFAOYSA-N;LY294002 (hydrochloride);NCGC00094060-01;2-(4-Morpholinyl)-8-phenyl-4H-1-ben zopyran-4-one hydrochloride;NCGC00094060-02;AKOS024456404;EU-0100710;GLXC-03300;AT34063;BCP17476;2-(MORPHOLIN-4-YL)-8-PHENYLCHROMEN-4-ONE HYDROCHLORIDE;2-morpholin-4-yl-8-phenylchromen-4-one;hydrochloride;AS-58350
SMILES:	Cl.O=C1C2C=CC=C(C=2OC(N2CCOCC2)=C1)C1C=CC=CC=1
Formula:	C₁₉H₁₈ClNO₃
M.Wt:	343.804124355316
Purity:	>98%
Sotrage:	2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

Cat. No.	Product name	Field of application
DC31074	Isopropyl myristate	Isopropyl myristate is the ester of isopropyl alcohol and myristic acid.
DC79609	NCGC00685960	NCGC00685960 is a Nicotinamide N-methyltransferase (NNMT) inhibitor with an IC50 < 10  nM. NCGC00685960 has potent antitumor activity. NCGC00685960 increases H3K27 trimethylation levels in ovarian cancer cells and inhibits α-SMA expression in NNMT-expressing ovarian fibroblasts. NCGC00685960 reduces 1-MNA levels, reverses SAM and H3K27 hypomethylation and significantly impairs collagen contractility in cancer-associated fibroblasts (CAFs). NCGC00685960 can be used for cancers research.
DC77813	Zeltociclib	Zeltociclib is a cyclin-dependent kinase inhibitor with antitumor effects.
DC77714	S3226	S3226 is an inhibitor for Na+/H+ exchange subtype 3 (NHE3) with an IC50 of 0.2 µmol/L in rat NHE3 transfected fibroblasts. S3226 exhibits protective activity in rat ischemia-induced acute renal failure models.
DC77822	JNJ-77242113 (Icotrokinr)	Icotrokinra (JNJ-77242113, JNJ-2113, PN-235) is an orally available and selective antagonist of the IL-23 receptor. It also inhibits IL-23–induced STAT3 phosphorylation in peripheral blood mononuclear cells with an IC50 of 5.6 pM and suppresses IL-23–induced IFN-γ production in NK cells with an IC50 of 18.4 pM. It also exhibits anti-inflammatory activity in a TNBS-induced colitis model in rats and holds potential for studying psoriasis, psoriatic arthritis, and inflammatory bowel disease.
DC75868	AZ14133346	AZ14133346 (compound 36) is a potent and selective inhibitor of EGFR Exon20 insertions, with the IC50 of 85 nM. AZ14133346 plays an important role in cancer research.
DC75865	TI17	TI17 represents a novel class of targeted anticancer agents that specifically disrupt DNA damage repair mechanisms in malignant cells.
DC75816	Nisoxetine	Nisoxetine acts as a highly selective and potent noradrenaline transporter (NET) antagonist, exhibiting a binding affinity (Kd) of 0.76 nM. In addition to its antidepressant properties, nisoxetine functions as a local anesthetic by inhibiting voltage-gated sodium channels. This dual pharmacological activity makes it a compound of interest for both neurological and pain management research.
DC75641	GENZ-644282 TFA salt	Genz-644282, also known as SAR402674, is a non-camptothecin inhibitor of topoisomerase I with potential antineoplastic activity. Topoisomerase I inhibitor Genz-644282 binds to and inhibits the enzyme topoisomerase I, which may result in the inhibition of repair of single-strand DNA breaks, DNA replication, and tumor cell growth in susceptible tumor cell populations.
DC75345	Sitagliptin Phosphate Monohydrate	Sitagliptin, also known as MK-0431, is a potent inhibitor of DPP4 with an IC50 of 19 nM in Caco-2 cell extracts. Sitagliptin is believed to exert its actions in patients with type 2 diabetes mellitus by slowing the inactivation of incretin hormones. By increasing and prolonging active incretin levels, sitagliptin increases insulin release and decreases glucagon levels in the circulation in a glucose-dependent manner. Sitagliptin demonstrates selectivity for DPP-4 and does not inhibit DPP-8 or DPP-9 activity in vitro at concentrations approximating those from therapeutic doses.